India's drug regulator inspected 90% of cough syrup makers, found lapses, official says
The agency is under pressure to tighten oversight of the $42 billion pharma industry, dominated by small manufacturers, after India-made cough syrups have been tied to the deaths of more than 140 children in Africa and Central Asia since 2022, denting its reputation as the “pharmacy of the world”
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (42/100)Sources
India's drug regulator inspected 90% of cough syrup makers, found lapses, official says
The agency is under pressure to tighten oversight of the $42 billion pharma industry, dominated by small manufacturers, after India-made cough syrups have been tied to the deaths of more than 140 children in Africa and Central Asia since 2022, denting its reputation as the “pharmacy of the world”
Read full article →90% of country’s cough syrup units inspected; 850 CAPA notices issued in quality crackdown: DCGI
Read full article →India’s drug regulator inspected 90% of cough syrup makers, found lapses, official says
Inspections followed discovery of Coldrif syrup linked to 24 child deaths last October
By Reuters
Read full article →


